|
LorfanDrug - Lorfan The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Levallorphan Tartrate
Strength -
1MG/ML
Applicant -
ROCHE
New Drug Application (NDA) Number -
010423
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Hoffmann La Roche Inc
Lorfan
Eligard 45mg/vial Injectable; Subcutaneous
Eligard 7.5mg/vial Injectable; Subcutaneous Xopenex Eq 0.0103% Base Solution; Inhalation Xopenex Eq 0.021% Base Solution; Inhalation Xopenex Eq 0.042% Base Solution; Inhalation Xopenex Eq 0.25% Base Solution; Inhalation Xopenex Hfa Eq 0.045mg Base/inh Aerosol, Metered; Inhalation Lorfan 1mg/ml Injectable; Injection Eligard 22.5mg/vial Injectable; Subcutaneous Eligard 30mg/vial Injectable; Subcutaneous NewDrugInformation |